ロード中...
Molecular markers of prognosis and therapeutic targets in metastatic colorectal cancer
Metastatic disease ultimately occurs in approximately 50–70% of patients presenting with colorectal cancer. In patients with advanced disease, there is significant variability in individual patient outcomes. To improve understanding of tumor behavior, markers such as KRAS and BRAF mutation status ar...
保存先:
| 出版年: | Surg Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5152574/ https://ncbi.nlm.nih.gov/pubmed/27566022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.suronc.2016.05.018 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|